With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for ...

Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

Plus, why shareholders vote down anti-DEI proposals, missed payments and layoffs at Selena Gomez's Wondermind and Meta's ...

After 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

With a late-stage trial win for its Norditropin heir in hand, Novo Nordisk is making good on plans to boost its profile in ...

A four-year saga will reach its climax on Wednesday, but the Commission president is likely to emerge relatively unscathed.

Dr. Binks joins Capricor in anticipation of potential approval of deramiocel in Q3 2025, bringing extensive experience in ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May: BofA ...